Table 1 Summary of the study population.
From: Genetically determined telomere length and multiple myeloma risk and outcome
MM cases | Controls | |
|---|---|---|
Country/region | ||
Denmark | 277 | 494 |
France | 330 | 176 |
Hungary | 83 | 75 |
Israel | 89 | 72 |
Italy | 231 | 227 |
Poland | 1043 | 262 |
Portugal | 126 | 120 |
Spain | 228 | 315 |
Total | 2407 | 1741 |
Sex | ||
Male | 53.26% | 51.92% |
Female | 46.74% | 48.08% |
Median age | 61.47 | 52.59 |
(25th – 75th percentile) | (55–68) | (42–65) |
Disease stage, Durie-Salmon | ||
1 | 179 | |
2 | 299 | |
3 | 757 | |
Total | 1235 | |
Disease stage, International Staging System | ||
1 | 324 | |
2 | 332 | |
3 | 366 | |
Total | 1022 | |
Vital status | ||
Alive | 902 | |
Deceased | 371 | |
Total | 1273 | |
